ArticlePharmaceuticals (Basel, Switzerland)2026
Efficacy and Safety of SA001 in Patients with Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Jaewon Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.